1 |
Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
DOI
ScienceOn
|
2 |
Cheung MC, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 1996;14:264-8.
DOI
|
3 |
Portmann C, Ludlow J, Joyce A, Chan FY. Antecedents to and outcomes of Rh(D) immunization: mater mothers hospital, Brisbane, 1988-1995. Aust N Z J Obstet Gynaecol 1997;37:1-12.
DOI
ScienceOn
|
4 |
Moise Jr KJ. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2002;100:600-11.
DOI
ScienceOn
|
5 |
Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-8.
DOI
ScienceOn
|
6 |
Geifman-Holzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood-a meta-analysis. Am J Obstet Gynecol 2006;195:1163-73.
DOI
ScienceOn
|
7 |
Aubin JT, Le Van Kim C, Mouro I, Colin Y, Bignozzi C, Brossard Y, et al. Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification. Br J Haematol 1997;98:356-64.
DOI
ScienceOn
|
8 |
Rouillac-Le Sciellour C, Puillandre P, Gillot R, Baulard C, Mé tral S, et al. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol Diagn 2004;8:23-31.
DOI
|
9 |
The UK expert working group. Cell-free fetal nucleic acids for non-invasive prenatal diagnosis. UK: The foundation for genomics and population health (The PHG foundation), 2009;43.
|
10 |
Hahn S, Holzgreve W. Prenatal diagnosis using fetal cells and cell-free fetal DNA in maternal blood: what is currently feasible? Clin Obstet Gynecol 2002;45:649-56.
DOI
ScienceOn
|
11 |
Hahn S, Chitty LS. Noninvasive prenatal diagnosis: current practice and future perspectives. Curr Opin Obstet Gynecol 2008;20:146-51.
DOI
ScienceOn
|
12 |
Daniels G, Finning K, Martin P, Massey E. Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 2009;29:101-7.
DOI
ScienceOn
|
13 |
Yang YH. Noninvasive prenatal diagnosis using cellfree fetal nucleic acids in maternal plasma: Clinical applications. The 41st conference on Korean Society of Medical Genetics; 2010 Nov 18; Korea, Korea: Korean Society of Medical Genetics 2010;195-228.
|
14 |
Chan KCA, Ding C, Gerovassili A, Yeung SW, Chiu RWK, Leung TN, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52:2211-8.
DOI
ScienceOn
|
15 |
Dhallan R, Guo X, Emche S, Damewood M, Bayliss P, Cronin M, et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 2007;369:474-1.
DOI
ScienceOn
|
16 |
Norbury G, Norbury CJ. Non-invasive prenatal diagnosis of single gene disorders: how close are we? Semin Fetal Neonatal Med 2008;13:76-83.
DOI
ScienceOn
|
17 |
Chim SSC, Tong YK, Chiu RWK, Lau TK, Leung TN, Chan LYS, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 2005;102:14753-8.
DOI
ScienceOn
|
18 |
Finning KM, Chitty LS. Non-invasive fetal sex determination: impact on clinical practice. Semin Fetal Neonatal Med 2008;13:69-75.
DOI
ScienceOn
|
19 |
Chitty L, Mistry B, Hogg J, Meaney C, Thomasson L, Norbury G, et al. Prospective register of outcomes of free-fetal DNA testing (PROOF)-results of the first year's audit. BSHG News 2007;37:8-9.
|
20 |
Chi C, Hyett JA, Finning KM, Lee CA, Kadir RA. Non-invasive first trimester determination of fetal gender: a new approach for prenatal diagnosis of haemophilia. BJOG 2006;113:239-42.
DOI
ScienceOn
|
21 |
Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005;365:2125-36.
DOI
ScienceOn
|
22 |
Lajic S, Wedell A, Bui T, Ritzé n EM, Holst M. Longterm somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1998;83:3872-80.
DOI
|
23 |
Rijnders RJ, van der Schoot CE, Bossers B, de Vroede MA, Christiaens GC. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 2001;98:374-8.
DOI
ScienceOn
|
24 |
Miller WL. Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1994;78:241-6.
DOI
ScienceOn
|
25 |
Chiu RWK, Lo YMD. Preanalytical issues for circulating DNA analysis: technical aspects, semantics and need for standardization. In: Bruns DE, Lo YMD, Wittwer CT, editors, Molecular testing in laboratory medicine: selections from clinical chemistry 1998-2001. Washington: AACC, 2002;309-10.
|
26 |
Hill M, Finning K, Martin P, Hogg J, Meaney C, Norbury G, et al. Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 2011 [n Press].
|
27 |
Chiu RW, Lo YM. The biology and diagnostic applications of fetal DNA and RNA in maternal plasma. Curr Top Dev Biol 2004;61:81-111.
|
28 |
Chiu RW, Poon LL, Lau TK, Leung TN, Wong EM, Lo YM. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001;47:1607-13.
|
29 |
Lee T, LeShane ES, Messerlian GM, Canick JA, Farina A, Heber WW, et al. Down syndrome and cell-free fetal DNA in archived maternal serum. Am J Obstet Gynecol 2002;187:1217-21.
DOI
ScienceOn
|
30 |
Angert RM, LeShane ES, Lo YM, Chan LY, Delli-Bovi LC, Bianchi DW. Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first- and third-trimester samples. Clin Chem 2003;49:195-8.
DOI
ScienceOn
|
31 |
Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem 2005;51:1598-604.
DOI
ScienceOn
|
32 |
Avent ND, Chitty LS. Noninvasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound. Prenat Diagn 2006;26:598-603.
DOI
ScienceOn
|
33 |
Traeger-Synodinos J. Real-time PCR for prenatal and preimplantation genetic diagnosis of monogenic diseases. Mol Aspects Med 2006;27:176-91.
DOI
ScienceOn
|
34 |
Hyett JA, Gardener G, Stojilkovic-Mikic T, Finning KM, Martin PG, Rodeck CH, et al. Reduction in diagnostic and therapeutic interventions by Noninvasive determination of fetal sex in early pregnancy. Prenat Diagn 2005;25:1111-6.
DOI
ScienceOn
|
35 |
Hromadnikova I, Houbova B, Hridelova D, Voslarova S, Kofer J, Komrska V, et al. Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of noninvasive fetal sex determination. Prenat Diagn 2003;23:235-8.
DOI
ScienceOn
|
36 |
Herzenberg LA, Bianchi DW, Schroder J, Cann HM, Iverson GM. Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci USA 1979;76:1453-5.
DOI
ScienceOn
|
37 |
Bianchi DW, Avent ND, Costa JM, van der Schoot CE. Non-invasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstet Gynecol 2005;106:841-4.
DOI
ScienceOn
|
38 |
Li Y, Wenzel F, Holzgreve W, Hahn S. Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation. Electrophoresis 2006;27:3889-96.
DOI
ScienceOn
|
39 |
Bianchi DW, Flint AF, Pizzimenti MF, Knoll JH, Latt SA. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci USA 1990;87:3279-83.
DOI
ScienceOn
|
40 |
Bianchi DW, Simpson JL, Jackson LG, Elias S, Holzgreve W, Evans MI, et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002;22:609-15.
DOI
ScienceOn
|
41 |
Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996;2:1035-7.
DOI
ScienceOn
|
42 |
Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-5.
DOI
ScienceOn
|
43 |
Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006;169:400-4.
DOI
ScienceOn
|
44 |
Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent ND, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007;27:415-8.
DOI
ScienceOn
|
45 |
Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, Poon PMK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
DOI
ScienceOn
|
46 |
Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996;93:705-8.
DOI
ScienceOn
|
47 |
Legler TJ, Liu Z, Mavrou A, Finning K, Hromadnikova I, Galbiati S. Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn 2007;27:824-9.
DOI
ScienceOn
|
48 |
Lo YMD, Zhang J, Leung TN, Lau TK, Chang AMZ, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218-24.
DOI
ScienceOn
|
49 |
Chitty LS, van der Schoot CE, Hahn S, Avent ND. SAFE-The Special Noninvasive Advances in Fetal and Neonatal Evaluation Network: aims and achievements. Prenat Diagn 2008;28:83-8.
DOI
ScienceOn
|